{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:27:48Z","timestamp":1792783668071,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Spanish Ministry of Science and Innovation (MICINN)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.biomaterials.2011.01.008","type":"journal-article","created":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T04:14:04Z","timestamp":1296533644000},"page":"2938-2952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"title":["Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy"],"prefix":"10.1016","volume":"32","author":[{"given":"Raquel","family":"Mej\u00edas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"P\u00e9rez-Yag\u00fce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes I.","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Acedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngeles","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Puerto","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo F.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2011.01.008_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.1100369","article-title":"Cancer immunotherapy: a treatment for the masses","volume":"305","author":"Blattman","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri1936","article-title":"Cancer despite immunosurveillance: immunoselection and immunosubversion","volume":"6","author":"Zitvogel","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00262-002-0309-z","article-title":"Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy","volume":"51","author":"Dredge","year":"2002","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1349-7006.2004.tb03248.x","article-title":"The critical role of type-1 innate and acquired immunity in tumor immunotherapy","volume":"95","author":"Ikeda","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib7","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1007\/PL00014051","article-title":"The critical role of Th1-dominant immunity in tumor immunology","volume":"46","author":"Nishimura","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.immunol.15.1.563","article-title":"The IFN gamma receptor: a paradigm for cytokine receptor signaling","volume":"15","author":"Bach","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/1074-7613(94)90087-6","article-title":"Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors","volume":"1","author":"Dighe","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib10","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","article-title":"Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice","volume":"95","author":"Kaplan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V97.1.192","article-title":"Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis","volume":"97","author":"Street","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.20020063","article-title":"Suppression of lymphoma and epithelial malignancies effected by interferon gamma","volume":"196","author":"Street","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1385\/IR:24:2:201","article-title":"Regulation of tumor growth by IFN-gamma in cancer immunotherapy","volume":"24","author":"Beatty","year":"2001","journal-title":"Immunol Res"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib14","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.0901073","article-title":"Responsiveness of stromal fibroblasts to IFN-gamma blocks tumor growth via angiostasis","volume":"183","author":"Lu","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jmmm.2005.02.053","article-title":"Morphological analysis of mouse lungs after treatment with magnetite-based magnetic fluid stabilized with DMSA","volume":"293","author":"Garcia","year":"2005","journal-title":"J\u00a0Magn Magn Mater"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jps.10007","article-title":"Interferon-gamma therapy: evaluation of routes of administration and delivery systems","volume":"91","author":"Younes","year":"2002","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11481-006-9032-4","article-title":"Nanotechnology: a focus on nanoparticles as a drug delivery system","volume":"1","author":"Kingsley","year":"2006","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1021\/mp7001285","article-title":"Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats","volume":"5","author":"Jain","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0169-409X(02)00044-3","article-title":"Nanoparticles in cancer therapy and diagnosis","volume":"54","author":"Brigger","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib21","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1016\/j.biomaterials.2004.10.012","article-title":"Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications","volume":"26","author":"Gupta","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1748-0132(07)70084-1","article-title":"Magnetic nanoparticles for drug delivery","volume":"2","author":"Arruebo","year":"2007","journal-title":"Nanotoday"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib24","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","article-title":"Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment","volume":"95","author":"Hobbs","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib25","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1023\/A:1025785505977","article-title":"Drug delivery and transport to solid tumors","volume":"20","author":"Jang","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib26","first-page":"3752","article-title":"Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size","volume":"55","author":"Yuan","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jmmm.2005.01.064","article-title":"Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system","volume":"293","author":"Neuberger","year":"2005","journal-title":"J\u00a0Magn Magn Mater"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.addr.2009.11.002","article-title":"Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging","volume":"62","author":"Veiseh","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib29","first-page":"6641","article-title":"Locoregional cancer treatment with magnetic drug targeting","volume":"60","author":"Alexiou","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/1061186031000150791","article-title":"Magnetic drug targeting\u2013biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment","volume":"11","author":"Alexiou","year":"2003","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib31","first-page":"2019","article-title":"Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting","volume":"27","author":"Alexiou","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00249-006-0042-1","article-title":"Targeting cancer cells: magnetic nanoparticles as drug carriers","volume":"35","author":"Alexiou","year":"2006","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0304-8853(02)00605-4","article-title":"Magnetic drug targeting: biodistribution and dependency on magnetic field strength","volume":"252","author":"Alexiou","year":"2002","journal-title":"J\u00a0Magn Magn Mater"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib34","first-page":"4694","article-title":"Preclinical experiences with magnetic drug targeting: tolerance and efficacy","volume":"56","author":"Lubbe","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib35","first-page":"1553","article-title":"Visualisation of tumour regression after local chemotherapy with magnetic nanoparticles \u2013 a pilot study","volume":"30","author":"Lyer","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib36","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1166\/jnn.2006.477","article-title":"Quantification of magnetic nanoparticles by magnetorelaxometry and comparison to histology after magnetic drug targeting","volume":"6","author":"Wiekhorst","year":"2006","journal-title":"J\u00a0Nanosci Nanotechnol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib37","first-page":"4686","article-title":"Clinical experiences with magnetic drug targeting: a phase I study with 4\u2019-epidoxorubicin in 14 patients with advanced solid tumors","volume":"56","author":"Lubbe","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib38","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1016\/j.biomaterials.2010.02.068","article-title":"Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer","volume":"31","author":"Maeng","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jps.20813","article-title":"Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast caner bearing mice","volume":"96","author":"Kommareddy","year":"2007","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib40","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1109\/TMAG.2002.802495","article-title":"Light microscopy and magnetic resonance characterization of a DMSA-coated magnetic fluid in mice","volume":"38","author":"Chaves","year":"2002","journal-title":"IEEE Trans Magn"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2008.05.028","article-title":"Cytokine adsorption\/release on uniform magnetic nanoparticles for localized drug delivery","volume":"130","author":"Mejias","year":"2008","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib42","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1016\/j.biomaterials.2010.01.057","article-title":"Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy","volume":"31","author":"Dilnawaz","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib43","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1021\/jp807820s","article-title":"Effect of nanoparticle and aggregate size on the relaxometric properties of MR contrast agents based on high quality magnetite nanoparticles","volume":"113","author":"Roca","year":"2009","journal-title":"J\u00a0Phys Chem B"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib44","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ab.2004.03.049","article-title":"Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells","volume":"331","author":"Riemer","year":"2004","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/ja0380852","article-title":"Monodisperse MFe2O4 (M\u00a0=\u00a0Fe, Co, Mn) nanoparticles","volume":"126","author":"Sun","year":"2004","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib46","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers\u2019 entry into the cell: relevance to drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nmat2442","article-title":"Understanding biophysicochemical interactions at the nano-bio interface","volume":"8","author":"Nel","year":"2009","journal-title":"Nat Mater"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib48","doi-asserted-by":"crossref","first-page":"115103","DOI":"10.1088\/0957-4484\/20\/11\/115103","article-title":"The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells","volume":"20","author":"Villanueva","year":"2009","journal-title":"Nanotechnology"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib49","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/j.biomaterials.2008.07.020","article-title":"Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles","volume":"29","author":"Vasir","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib50","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1016\/j.biomaterials.2008.06.002","article-title":"The effect of silica nanoparticle-modified surfaces on cell morphology, cytoskeletal organization and function","volume":"29","author":"Lipski","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib51","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/smll.200500492","article-title":"Adverse effects of citrate\/gold nanoparticles on human dermal fibroblasts","volume":"2","author":"Pernodet","year":"2006","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cmmi.282","article-title":"Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes","volume":"4","author":"Soenen","year":"2009","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","article-title":"Toxicity determined in vitro by morphological alterations and neutral red absorption","volume":"24","author":"Borenfreund","year":"1985","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib55","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/bp00024a017","article-title":"Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations","volume":"9","author":"Altman","year":"1993","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib56","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1166\/jnn.2008.275","article-title":"In vitro biological activities of anionic gamma-Fe2O3 nanoparticles on human melanoma cells","volume":"8","author":"de Freitas","year":"2008","journal-title":"J\u00a0Nanosci Nanotechnol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2217\/nnm.10.15","article-title":"Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles","volume":"5","author":"Mejias","year":"2010","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib58","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.biomaterials.2009.09.053","article-title":"The effect of DMSA-functionalized magnetic nanoparticles on transendothelial migration of monocytes in the murine lung via a beta2 integrin-dependent pathway","volume":"31","author":"Valois","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib59","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1166\/jnn.2009.049","article-title":"Expression patterns of cell adhesion molecules in mice\u2019s lung after administration of meso-2,3-dimercaptosuccinic acid-coated maghemite nanoparticles","volume":"9","author":"Valois","year":"2009","journal-title":"J\u00a0Nanosci Nanotechnol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib60","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1088\/0031-9155\/52\/16\/022","article-title":"The role of dipolar interaction in the quantitative determination of particulate magnetic carriers in biological tissues","volume":"52","author":"Lopez","year":"2007","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib61","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbadis.2004.11.020","article-title":"Magnetic characterisation of rat muscle tissues after subcutaneous iron dextran injection","volume":"1740","author":"Lazaro","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib62","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib63","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib64","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.0105-2896.2004.00199.x","article-title":"Cytokines in cancer immunity and immunotherapy","volume":"202","author":"Smyth","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib65","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib66","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jinorgbio.2006.06.010","article-title":"Bioinorganic transformations of liver iron deposits observed by tissue magnetic characterisation in a rat model","volume":"100","author":"Gutierrez","year":"2006","journal-title":"J\u00a0Inorg Biochem"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib67","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.4049\/jimmunol.167.9.5286","article-title":"Analysis of in situ NK cell responses during viral infection","volume":"167","author":"Dokun","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib68","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ni796","article-title":"In vivo developmental stages in murine natural killer cell maturation","volume":"3","author":"Kim","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib69","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.162.2.718","article-title":"The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections","volume":"162","author":"Tay","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib70","first-page":"463","article-title":"Cytokine- and chemokine-based gene therapy for cancer","volume":"5","author":"Chada","year":"2003","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib71","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity and cancer immunoediting","volume":"6","author":"Dunn","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib72","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1200\/JCO.1986.4.2.234","article-title":"Clinical toxicity of interferons in cancer patients: a review","volume":"4","author":"Quesada","year":"1986","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.biomaterials.2011.01.008_bib73","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archotol.128.8.880","article-title":"The role of intratumoral therapy with cisplatin\/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neck","volume":"128","author":"Wenig","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961211000093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961211000093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:29:20Z","timestamp":1758900560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961211000093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0142961211000093"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2011.01.008","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2011.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}